معرفی
Jan Deprest serves as a full Professor at KU Leuven's Faculty of Medicine, where he heads the Urogenital, Abdominal and Plastic Surgery unit within the Department of Development and Regeneration. His leadership extends to multiple institutional roles including membership in iSi Health - KU Leuven Institute for Physics-based Modeling for In Silico Health and Leuven.IRD - KU Leuven Institute for Rare Diseases, along with participation in various evaluation committees and faculty councils.
His research spans cutting-edge fetal surgical interventions, minimally invasive techniques, and pelvic floor reconstruction. Current projects focus on innovative solutions for congenital conditions including the Vortex Shunt for urinary tract obstruction, AI-enhanced pelvic imaging, miniature flexible robots for gynecological procedures, and in-situ 3D bioprinting for spina bifida treatment. His work bridges engineering advancements with clinical applications to improve perinatal outcomes.
Analysis of his recent publications reveals a strong emphasis on translational research connecting fetal diagnostics with therapeutic interventions. His team produces high-impact work in top journals covering congenital diaphragmatic hernia management, spina bifida repair outcomes, pelvic floor dysfunction, and AI-assisted obstetric imaging, demonstrating consistent contributions to advancing fetal medicine and reconstructive surgery.
As an educator, Professor Deprest teaches multiple courses in gynecology and obstetrics, including specialized modules on sexual health, gynecological skills development, and problem-solving approaches in women's healthcare. His supervisory role extends to doctoral candidates like Page, A-S., whose 2025 thesis focused on innovative pelvic floor therapies.
Professor Deprest leads numerous active research projects funded through KU Leuven, with several extending through 2028-2029. His laboratory work encompasses fetal lamb models for surgical device testing, AI algorithm development for medical imaging, and tissue engineering approaches for congenital defect correction, maintaining KU Leuven's position at the forefront of fetal surgical innovation.